Determination of (+)-3,3′,5,5′-Tetraiodo-L-thyronine (L-T₄) in Serum and Pharmaceutical Formulations using a Sequential Injection Analysis/Immunosensor System

Raluca-Ioana Stefan-van Staden Laboratory of Electrochemistry Bucharest, National Institute of Research for Electrochemistry and Condensed Matter, Bucharest, RomaniaCorrespondence[email protected]

Jacobus Frederick van Staden Laboratory of Electrochemistry Bucharest, National Institute of Research for Electrochemistry and Condensed Matter, Bucharest, Romania

Hassan Y. Aboul-Enein Medicinal and Pharmaceutical Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Center (NRC), Dokki, Cairo, Egypt

Marius Constantin Mirica National Institute of Research for Electrochemistry and Condensed Matter, Timisoara, Romania

Ionel Balcu National Institute of Research for Electrochemistry and Condensed Matter, Timisoara, Romania

Nicolae Mirica National Institute of Research for Electrochemistry and Condensed Matter, Timisoara, Romania

Determination of (+)-3,3′,5,5′-Tetraiodo-L-thyronine (L-T₄) in Serum and Pharmaceutical Formulations using a Sequential Injection Analysis/Immunosensor System

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Determination of (+)-3,3′,5,5′-Tetraiodo-L-thyronine (L-T4) in Serum and Pharmaceutical Formulations using a Sequential Injection Analysis/Immunosensor System

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Determination of (+)-3,3′,5,5′-Tetraiodo-L-thyronine (L-T₄) in Serum and Pharmaceutical Formulations using a Sequential Injection Analysis/Immunosensor System